Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients
© The Author 2016. Background: Child-friendly, low-cost, solid, oral fixed-dose combinations (FDCs) of efavirenz with lamivudine and abacavir are urgently needed to improve clinical management and drug adherence for children. Methods: Data were pooled from several clinical trials and therapeutic dru...
Saved in:
Main Authors: | Bouazza N., Cressey T., Foissac F., Bienczak A., Denti P., McIlleron H., Burger D., Penazzato M., Lallemant M., Capparelli E., Treluyer J., Urien S. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85014551564&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/41174 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients
by: Naïm Bouazza, et al.
Published: (2018) -
Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients
by: Naïm Bouazza, et al.
Published: (2018) -
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children
by: Chokephaibulkit K., et al.
Published: (2014) -
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children
by: Chokephaibulkit K., et al.
Published: (2014) -
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children
by: Kulkanya Chokephaibulkit, et al.
Published: (2018)